Study Summary
This trial will evaluate a new surgical approach to treating post-mastectomy pain caused by nerve damage. The hope is that this will improve patients' quality of life.
Eligible Conditions
- Post-Mastectomy Pain Syndrome
Treatment Effectiveness
Effectiveness Progress
Study Objectives
5 Primary · 0 Secondary · Reporting Duration: Baseline to 12 - 24 months
Month 24
Change in depression/anxiety scores
Change in opioid consumption
Change in pain level
Up to 24 months
Freedom from neuroma recurrence evaluated by physical exam
Freedom from neuroma recurrence evaluated by ultrasound
Trial Safety
Safety Progress
Trial Design
0 Treatment Group
25 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 12 - 24 months
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,069 Previous Clinical Trials
41,129,383 Total Patients Enrolled
University of Michigan Rogel Cancer CenterLead Sponsor
267 Previous Clinical Trials
18,106 Total Patients Enrolled
David L Brown, M.D.Principal InvestigatorUniversity of Michigan
Eligibility Criteria
Age 18+ · Female Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments